Please note: The information displayed on this page might be outdated.
Philogen: Developer of biopharmaceuticals for the treatment of angiogenesis-related disorders. The company is engaged in the discovery and development of novel biopharmaceutical products and offers antibody derivatives for the treatment of certain cancers cancer, rheumatoid arthritis and age-related macular degeneration.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase III, Phase l or ll, Pre-Clinical Stage
Disease Space
Anti-inflammatory, Oncology
Finance
Pre-Revenues
Industry
Biotechnology, Pharmaceuticals
Listing
Europe, Private
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Cell Therapy
Website:
Address:
Via Bellaria, 35
Sovicille, 53018
Italy

Company Participants at European Biotech Investor Day 2020

  • Dario Neri

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.